Preeclampsia Circulating and Placental Growth-Differentiation Factor 15 in Preeclampsia and in Pregnancy Complicated by Diabetes Mellitus
暂无分享,去创建一个
F. Luft | R. Dechend | K. Wollert | F. Herse | T. Kempf | M. Sugulle | G. M. Johnsen | M. S. Weedon-Fekjaer | L. Anton | K. Brosnihan | A. Cathrine
[1] D. Merrill,et al. Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study , 2010, Reproductive biology and endocrinology : RB&E.
[2] K. Kos,et al. Identification of macrophage inhibitory cytokine-1 (MIC-1) in adipose tissue and its secretion as an adipokine by human adipocytes , 2009, Proceedings of the Nutrition Society.
[3] L. Wallentin,et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. , 2007, European heart journal.
[4] A. Hingorani,et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[5] R. Harskamp,et al. Preeclampsia: At Risk for Remote Cardiovascular Disease , 2007, The American journal of the medical sciences.
[6] D. Charnock-Jones,et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. , 2007, The American journal of pathology.
[7] P. Ponikowski,et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.
[8] A. Clerk,et al. Cardiac myocyte gene expression profiling during H2O2-induced apoptosis. , 2007, Physiological genomics.
[9] G. Wallukat,et al. Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia , 2007, Hypertension.
[10] R. Califf,et al. Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome , 2007, Circulation.
[11] G. Brabant,et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. , 2007, Clinical chemistry.
[12] G. Burton,et al. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. , 2006, Taiwanese journal of obstetrics & gynecology.
[13] A. Barden. PRE‐ECLAMPSIA: CONTRIBUTION OF MATERNAL CONSTITUTIONAL FACTORS AND THE CONSEQUENCES FOR CARDIOVASCULAR HEALTH , 2006, Clinical and experimental pharmacology & physiology.
[14] T. Wilsgaard,et al. Longitudinal reference ranges for estimated fetal weight , 2006, Acta obstetricia et gynecologica Scandinavica.
[15] T. Hewett,et al. GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein Activation , 2006, Circulation research.
[16] H. Drexler,et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. , 2006, Circulation research.
[17] M. Olovsson,et al. The risk of maternal ischaemic heart disease after gestational hypertensive disease , 2005 .
[18] A. Staff,et al. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. , 2005, American journal of obstetrics and gynecology.
[19] I. Sargent,et al. Latest Advances in Understanding Preeclampsia , 2005, Science.
[20] B. Roald,et al. The decidual suction method: a new way of collecting decidual tissue for functional and morphological studies , 2004, Acta obstetricia et gynecologica Scandinavica.
[21] L. Myatt,et al. Oxidative stress in the placenta , 2004, Histochemistry and Cell Biology.
[22] L. Duley. Pre-eclampsia and the hypertensive disorders of pregnancy. , 2003, British medical bulletin.
[23] R. Voutilainen,et al. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.
[24] L. Vatten,et al. Intrauterine Exposure to Preeclampsia and Adolescent Blood Pressure, Body Size, and Age at Menarche in Female Offspring , 2003, Obstetrics and gynecology.
[25] S. Breit,et al. Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. , 2003, Placenta.
[26] Catherine Kim,et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.
[27] W. D. Fairlie,et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study , 2002, The Lancet.
[28] R. T. Lie,et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.
[29] W. D. Fairlie,et al. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. , 2000, The Journal of clinical endocrinology and metabolism.
[30] L. Roberts,et al. Placental isoprostane is significantly increased in preeclampsia , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] H. Gjessing,et al. Birthweight by gestational age in Norway , 2000, Acta obstetricia et gynecologica Scandinavica.
[32] T. Henriksen,et al. Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia. , 1999, American journal of obstetrics and gynecology.
[33] N. Schneiderman,et al. History of gestational diabetes, insulin resistance and coronary risk. , 1999, Journal of diabetes and its complications.
[34] I. Sargent,et al. Preeclampsia: An Excessive Maternal Inflammatory Response to Pregnancy , 1999 .
[35] T. Henriksen,et al. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. , 1999, American journal of obstetrics and gynecology.
[36] W. D. Fairlie,et al. MIC‐1 is a novel TGF‐β superfamily cytokine associated with macrophage activation , 1999, Journal of leukocyte biology.
[37] L. Weissfeld,et al. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. , 1998, Metabolism: clinical and experimental.
[38] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[39] S. Vukicevic,et al. Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family* , 1998, The Journal of Biological Chemistry.
[40] M. Soares,et al. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. , 1997, Gene.
[41] W. D. Fairlie,et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] Mihoro Saeki,et al. Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta. , 1997, Journal of biochemistry.
[43] A. Waage,et al. Interleukin‐1, interleukin‐6 and tumor necrosis factor at delivery in preeclamptic disorders , 1995, Acta obstetricia et gynecologica Scandinavica.
[44] James M. Roberts,et al. Preeclampsia: More Than Pregnancy‐Induced Hypertension , 1994 .
[45] M. D'Alton,et al. Preeclampsia in diabetic pregnancies , 1991 .